Clinical Trial Update: A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tanezumab as add-on therapy to opioids for cancer-related bone metastasis pain; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm Metastasis
• Palliative Care

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Neoplasm Metastasis, Palliative Care | Phase 2 | Status: COMPLETED | Results posted: 2021-06-18